VBI Vaccines Inc.
VBIV · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13 | $24 | $35 | $21 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $1 | $4 | $2 |
| Inventory | $10 | $8 | $8 | $7 |
| Other Curr. Assets | $0 | $0 | $3 | $1 |
| Total Curr. Assets | $26 | $36 | $50 | $32 |
| Property Plant & Equip (Net) | $11 | $12 | $9 | $13 |
| Goodwill | $1 | $1 | $2 | $2 |
| Intangibles | $36 | $36 | $36 | $40 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $3 | $1 |
| Total NC Assets | $49 | $51 | $51 | $56 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $75 | $87 | $101 | $88 |
| Liabilities | – | – | – | – |
| Payables | $9 | $6 | $7 | $7 |
| Short-Term Debt | $50 | $52 | $50 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $13 | $11 | $7 | $1 |
| Other Curr. Liab. | $3 | $4 | $5 | $6 |
| Total Curr. Liab. | $78 | $76 | $77 | $28 |
| LT Debt | $1 | $1 | $1 | $50 |
| Deferred Rev, NC | $2 | $2 | $2 | $2 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | -$1 | -$1 | -$1 | -$1 |
| Total NC Liab. | $3 | $4 | $4 | $52 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $2 | $3 |
| Total Liabilities | $81 | $79 | $81 | $80 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $455 | $454 | $454 | $442 |
| Retained Earnings | -$600 | -$582 | -$582 | -$562 |
| AOCI | $32 | $28 | $42 | $35 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$5 | $8 | $20 | $9 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $75 | $87 | $101 | $88 |
| Net Debt | $38 | $29 | $16 | $32 |